NHS Framework Agreement for the supply of Icatibant & C1 Esterase products for the treatment of Hereditary Angioedema

A Pipeline Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Potential Contract ()
Duration
1 year
Value
£15M
Sector
HEALTH
Published
02 Nov 2021
Delivery
01 Jul 2022 to 30 Jun 2023
Deadline
n/a

Concepts

Location

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

Icatibant, C1 Esterase products for the treatment of Hereditary Angioedema

Total Quantity or Scope

YEAR: 2022/2023; BUDGET: 11,250,000.00 YEAR: 2023/2024; BUDGET: 3,750,000.00

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Reference

Domains